• Interaction Score: 2.1

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Novel drug target Novel Target
    Trial Name YM-178
    Mechanism of Interaction Beta-3 adrenergic receptor agonist

  • Interaction Score: 0.17

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Specific Action of the Ligand Agonist
    Endogenous Drug? False
    Direct Interaction? False

    PMIDs:
    None found


  • Interaction Score: 0.12

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Direct Interaction? False
    Endogenous Drug? False
    Specific Action of the Ligand Agonist

    PMIDs:
    None found


  • Interaction Score: 0.05

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    PharmGKB FDA

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications for treatment of overactive bladder
    Drug Class small molecule
    FDA Approval not approved

    Publications:

    • Version: 2020.06.01

    Alternate Names:
    D0X5UN TTD Drug ID

    Drug Info:

    Publications:

    • Version: 29-September-2020

    Alternate Names:
    MIRABEGRON GuideToPharmacology Ligand Name

    Drug Info:

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

    • Version: 04-September-2020

    Alternate Names:

    Drug Info:

    Publications:

    • Version: 18-August-2020

    Alternate Names:

    Drug Info:

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: